A recent large survey conducted in three regions of north and west Ethiopia and estimated that HRP2-based RDTs would miss 9.7% of symptomatic falciparum malaria cases owing to deletion of the P. falciparum histidine-rich protein 2 (hrp2) genes [11]. The gene discussed is HDGFL2; the disease is Plasmodium falciparum malaria.